Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Equities
  • ETFs
  • Markets

Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness

By Benzinga Neuro
June 10, 10:28 PM
On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a recent trend of the investment firm adjusting its portfolio.

ARCT

Read More
3 minute read
  • Analyst Ratings

A Glimpse Into The Expert Outlook On Veracyte Through 4 Analysts

By Benzinga Insights
May 8, 11:00 AM
4 analysts have expressed a variety of opinions on Veracyte (NASDAQ:VCYT) over the past quarter, offering a diverse…

VCYT

Read More
4 minute read
  • Biotech
  • General
  • News

Veracyte Announces Data From 14 Studies Presented At AUA 2024 Show Decipher Tests’ Ability To Help Personalize Care For Prostate And Bladder Cancer Patients And Advance Disease Understanding

By Benzinga Newsdesk
May 6, 4:30 PM
Large number of abstracts also showcases power of the Veracyte Diagnostics PlatformVeracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that data from 14 presentations at AUA 2024, the

VCYT

Read More
2 minute read
  • Biotech
  • General
  • News

Veracyte’s New Study Shows The Decipher Prostate Test Is Prognostic For Prostate Cancer Progression Among Patients Undergoing Active Surveillance

By Benzinga Newsdesk
April 22, 8:42 AM
Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate cancer,

VCYT

Read More
2 minute read
  • Biotech
  • General
  • News

Veracyte Announces 9 Abstracts Reinforcing The Value Of Decipher Prostate And Decipher Bladder Testing Will Be Presented At AUA 2024

By Benzinga Newsdesk
April 16, 8:42 AM
Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that nine abstracts focused on its Decipher Prostate and Decipher Bladder Genomic Classifiers will be presented at AUA 2024, the annual

VCYT

Read More
3 minute read
  • Equities
  • ETFs
  • Markets
  • News

Cathie Wood’s Ark Invest Buys Over $92M Worth Of ProShares Bitcoin ETF, Sells Coinbase, Block And Palantir Shares

By Benzinga Neuro
December 28, 12:19 AM
On Wednesday, Cathie Wood-led Ark Invest made a significant move in the cryptocurrency space, purchasing over $92 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO).

AMD

Read More
4 minute read
  • Biotech
  • General
  • News

Clinical Validation Data Published In CHEST Demonstrate That Veracyte’s Percepta Nasal Swab Test Improves Lung Cancer Risk Assessment For Patients With Lung Nodules

By Benzinga Newsdesk
November 29, 9:35 AM
Non-invasive genomic test is designed to help physicians guide next steps for current and former smokers with lung nodulesVeracyte, Inc. (NASDAQ:VCYT) announced that clinical validation data published in the journal

VCYT

Read More
1 minute read
  • Earnings

Veracyte: Q3 Earnings Insights

By Benzinga Insights
November 7, 5:35 PM
Veracyte (NASDAQ:VCYT) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:05 PM. Here’s what investors…

VCYT

Read More
2 minute read
  • Biotech
  • General
  • News

Veracyte Announces In Vitro Diagnostic Agreement With Illumina To Broaden Availability Of Its Tests For Patients Globally

By Benzinga Newsdesk
November 7, 5:01 PM
Agreement is part of Veracyte's multi-platform strategy for its decentralized IVD tests outside of the U.S.Veracyte, Inc. (NASDAQ:VCYT) today announced that it has entered into a multi-year agreement with Illumina, Inc.

ILMN

Read More
25 minute read
  • Earnings

Earnings Scheduled For November 7, 2023

By Benzinga Insights
November 7, 7:34 AM
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

ABUS

Posts pagination

1 2 … 5 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service